News

CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...
GSK's Blenrep approved in the U.K. for multiple myeloma after strong phase 3 data showing improved survival in DREAMM-7 and ...
Pharma with 3,615 puts trading, or 1.6x expected. Most active are May-25 30 puts and Aug-25 35 puts, with total ...
GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...
Zacks Investment Research on MSN3d
Here's Why GSK (GSK) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...
Nifty surged 4.5% this week to 23,852, its biggest weekly gain since Feb 2021. HDFC Bank, ICICI Bank, Bharti Airtel and Bajaj ...
GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines ...
GSK plc (LSE/NYSE: GSK) today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has voted to recommend use of PENMENVY ...
Euro US Dollar, British Pound US Dollar, FTSE 100, Taylor Wimpey PLC. Read 's Market Analysis on Investing.com ...
LVMH lost its position on Tuesday as Europe's largest luxury company in terms of market capitalization after being overtaken by rival Hermes due to investor pessimism after disappointing first-quarter ...